NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes and other metrics for its global derivatives and cash equities exchanges for December 20091. Trading volumes in December 2009 were mixed, with European Derivatives volumes increasing 40.8% and U.S. options trading volumes increasing 92.2% versus prior year. U.S. and European cash equities trading volumes, however, declined 30.5% and 9.1%, respectively, from prior year levels.

Highlights

• NYSE Euronext European derivatives products average daily volume (“ADV”) in December 2009 of 4.0 million contracts increased 40.8% compared to December 2008, but decreased 6.8% from November 2009. Total European interest rate products ADV in December 2009 of 1.8 million contracts increased 51.8% compared to December 2008, but decreased 21.5% from November 2009. Total equity products ADV of 2.1 million contracts in December 2009 increased 33.1% compared to December 2008, and increased 10.6% from November 2009.
• NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.1 million contracts in December 2009 increased 92.2% compared to December 2008 levels and increased 3.0% from November 2009. NYSE Group’s U.S. options exchanges accounted for 24.9% of the total consolidated equity options trading in December 2009, up from 17.4% in December 2008 and 24.7% in November 2009. December 2009 represented the fourth consecutive monthly increase in market share across NYSE Group U.S. equity options exchanges.
• NYSE Euronext European cash products ADV of 1.1 million transactions in December 2009 decreased 9.1% compared to December 2008, and decreased 17.7% from November 2009.
• NYSE Group (NYSE, NYSE Arca and NYSE Amex) U.S. cash products handled ADV of 2.3 billion shares in December 2009 decreased 30.5% compared to December 2008 and decreased 5.7% compared to November 2009. NYSE Group matched share of all U.S. equity trading volume was 28.2% in December 2009 and compared to matched market share of 22.0% for our next largest competitor. NYSE Group’s Tape A matched market share in December 2009 was 36.5%, down slightly from November 2009 levels.
• There were a total of 22 trading days in Europe and 22 trading days in the U.S. in December 2009, compared to 21 trading days in Europe and 22 trading days in the U.S. in December 2008.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in December 2009 was 4.0 million futures and options contracts, an increase of 40.8% from December 2008, and a decrease of 6.8% from November 2009. The 4.0 million in futures and options contracts ADV in December 2009 consisted of 2.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.1 million, or 27.5%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
• In the fourth quarter of 2009, European derivatives products ADV was 4.1 million contracts, 10.1% above the fourth quarter of 2008. The 4.1 million in futures and options contracts ADV in the fourth quarter of 2009 consisted of 3.2 million contracts executed through LIFFE CONNECT and 0.9 million contracts, or 21.4%, executed through Bclear. For the full-year 2009, European derivatives products ADV of 4.1 million contracts was 0.6% above 2008 levels.
• Total interest rate products ADV of 1.8 million contracts in December 2009 increased 51.8% from December 2008, but decreased 21.5% from November 2009. In the fourth quarter of 2009, interest rate products ADV of 2.0 million contracts was up 17.5% from the fourth quarter of 2008. For the full-year 2009, total interest rate products ADV of 2.0 million contracts decreased 6.7% compared to full-year 2008.
• Total equity products (including Bclear) ADV of 2.1 million contracts in December 2009 increased 33.1% compared to December 2008, and increased 10.6% compared to November 2009. In the fourth quarter of 2009, total equity products ADV of 2.0 million contracts, including 1.1 million contracts executed through LIFFE CONNECT, was 3.3% above the 1.9 million contracts executed in the fourth quarter of 2008, which included 1.2 million contracts executed through LIFFE CONNECT. For the full-year 2009, total equity products ADV increased 9.3% compared to 2008 driven primarily by a 36.7% increase in volume executed through Bclear.

U.S. Derivatives

• NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.1 million contracts in December 2009 increased 92.2% compared to December 2008, and increased 3.0% compared to November 2009. In the fourth quarter of 2009, NYSE group U.S. equity options ADV of 3.1 million contracts increased 49.3% compared to the fourth quarter of 2008. For the full-year 2009, NYSE Group U.S. equity options volume of 2.6 million contracts was 44.9% above the prior year period driven primarily by the addition of the former Amex options business.
• Total U.S. consolidated options ADV increased 34.4% to 12.4 million contracts in December 2009 compared to December 2008 and increased 2.4% compared to November 2009. In the fourth quarter of 2009, U.S. consolidated options ADV of 12.9 million contracts increased 7.8% compared to the fourth quarter of 2008. For the full-year 2009, U.S. consolidated options ADV of 13.4 million contracts was 2.9% above full-year 2008 levels.
• NYSE Group’s U.S. options exchanges accounted for 24.9% of the total consolidated equity options trading in December 2009, up from 17.4% in December 2008, and 24.7% in November 2009. December 2009 represented the fourth consecutive monthly increase in market share across NYSE Group U.S. options exchanges.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in December 2009 was approximately 20,000 contracts compared to 22,000 contracts in November 2009.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.1 million transactions in December 2009 decreased 9.1%, compared to December 2008, and decreased 17.7% compared to November 2009. In the fourth quarter of 2009, European cash products ADV of 1.3 million transactions decreased 18.0% compared to the fourth quarter of 2008. For the full-year 2009, European cash products ADV of 1.4 million transactions was 11.8% below full-year 2008 levels.

U.S. Cash

• NYSE Group U.S. cash products handled ADV in December 2009 decreased 30.5% to 2.3 billion shares, compared to December 2008, and decreased 5.7% from November 2009. In the fourth quarter of 2009, handled ADV of 2.6 billion shares was 37.1% below the fourth quarter of 2008. For the full-year 2009, NYSE Group handled ADV of 3.3 billion shares was 7.2% below full-year 2008 levels. NYSE Group matched share of all U.S. equity volume in December 2009 was 28.2%.
• NYSE Group’s Tape A matched market share in December 2009 was 36.5%, down from 36.8% in November 2009, and compared to matched market share of 17.5% for our next largest competitor. The market share representing off-exchange trades reported to the Trade Reporting Facilities of FINRA increased 250 basis points from November to December, while NYSE Group’s market share declined only 30 basis points. Tape A matched market share for NYSE Classic was 26.0% in December 2009, above the 25.7% market share reported in November 2009 and above the 25.0% monthly average recorded in 2009.
• Designated Market Maker (“DMM”) participation in December 2009 was 8.3%, compared to 8.6% in November 2009. Supplemental Liquidity Provider (“SLP”) participation in December 2009 was 10.3%, compared to 11.8% in November 2009. DMM and SLP participation pertain only to trading on NYSE.

Exchange Traded Products

• NYSE Group matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 250 million shares in December 2009 decreased 51.0% compared to December 2008, and decreased 19.6% compared to November 2009. In the fourth quarter of 2009, matched exchange-traded products ADV of 302 million shares was 53.3% below the fourth quarter of 2008. For the full-year 2009, exchange-traded products matched ADV of 440 million shares was 2.1% below the full-year 2008.

Other Metrics

• The average EUR/USD exchange rate for the fourth quarter of 2009 of $1.48 represented an increase of 3.2% from the third quarter of 2009 and an increase of 11.9% compared to the fourth quarter of 2008. For the full-year 2009, the average EUR/USD exchange rate of $1.39 was 5.2% below full-year 2008.
• The average GBP/USD exchange rate for the fourth quarter of 2009 of $1.63 represented a decrease of 0.5% from the third quarter of 2009, but an increase of 4.0% compared to the fourth quarter of 2008. For the full-year 2009, the average GBP/USD exchange rate of $1.57 was 15.5% below full-year 2008.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE Amex -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2008 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary - Cash Products

                    Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited) Dec-09 Dec-08 % Chg Dec-09 Dec-08 % Chg YTD 2009

% Chg vs.

YTD 2008

YTD 2009

% Chg vs.

YTD 2008

  Number of Trading Days - European Markets 22 21 22 21 256 256 Number of Trading Days - U.S. Markets 22 22 22 22 252 252   European Cash Products (trades in thousands) 1,087 1,196 -9.1 % 23,916 25,116 -4.8 % 1,368 -11.8 % 350,281 -11.8 %   Equities 1,041 1,141 -8.7 % 22,903 23,952 -4.4 % 1,310 -12.5 % 335,405 -12.5 % Exchange-Traded Funds 12 11 12.8 % 267 226 18.2 % 14 55.5 % 3,677 55.5 % Structured Products 28 40 -29.2 % 621 837 -25.9 % 38 -4.0 % 9,745 -4.0 % Bonds 6 5 19.4 % 125 100 25.0 % 6 10.1 % 1,455 10.1 %   U.S. Cash Products (shares in millions) 2 2,319 3,334 -30.5 % 51,011 73,347 -30.5 % 3,281 -7.2 % 826,739 -7.6 %  

NYSE Listed (Tape A) Issues 1

  NYSE Group Handled Volume 2 1,747 2,377 -26.5 % 38,434 52,300 -26.5 % 2,398 -7.2 % 604,231 -7.6 % NYSE Group Matched Volume 3 1,621 2,155 -24.8 % 35,669 47,414 -24.8 % 2,183 -6.4 % 550,000 -6.7 % Total NYSE Listed Consolidated Volume 4,443 4,967 -10.6 % 97,737 109,278 -10.6 % 5,686 11.2 % 1,432,761 10.8 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 39.3 % 47.9 % -8.6 % 39.3 % 47.9 % -8.6 % 42.2 % -8.4 % 42.2 % -8.4 % Matched Volume 3 36.5 % 43.4 % -6.9 % 36.5 % 43.4 % -6.9 % 38.4 % -7.2 % 38.4 % -7.2 %   NYSE Arca & Amex (Tape B) Listed Issues   NYSE Group Handled Volume 2 308 603 -48.9 % 6,786 13,276 -48.9 % 514 3.7 % 129,457 3.3 % NYSE Group Matched Volume 3 271 519 -47.9 % 5,954 11,420 -47.9 % 450 4.9 % 113,278 4.5 % Total NYSE Arca & Amex Listed Consolidated Volume 1,191 1,848 -35.6 % 26,208 40,666 -35.6 % 1,888 26.8 % 475,653 26.3 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 25.9 % 32.6 % -6.7 % 25.9 % 32.6 % -6.7 % 27.2 % -6.1 % 27.2 % -6.1 % Matched Volume 3 22.7 % 28.1 % -5.4 % 22.7 % 28.1 % -5.4 % 23.8 % -5.0 % 23.8 % -5.0 %   Nasdaq Listed (Tape C) Issues   NYSE Group Handled Volume 2 263 353 -25.5 % 5,791 7,771 -25.5 % 369 -19.0 % 93,050 -19.3 % NYSE Group Matched Volume 3 215 292 -26.3 % 4,731 6,421 -26.3 % 301 -21.0 % 75,887 -21.3 % Total Nasdaq Listed Consolidated Volume 1,830 1,866 -1.9 % 40,256 41,055 -1.9 % 2,236 -1.9 % 563,411 -2.3 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 14.4 % 18.9 % -4.5 % 14.4 % 18.9 % -4.5 % 16.5 % -3.5 % 16.5 % -3.5 % Matched Volume 3 11.8 % 15.6 % -3.8 % 11.8 % 15.6 % -3.8 % 13.5 % -3.2 % 13.5 % -3.2 %   Exchange-Traded Funds 1,4   NYSE Group Handled Volume 2 282 592 -52.3 % 6,207 13,021 -52.3 % 502 -2.8 % 126,431 -3.1 % NYSE Group Matched Volume 3 250 511 -51.0 % 5,499 11,233 -51.0 % 440 -2.1 % 110,970 -2.5 % Total ETF Consolidated Volume 1,121 1,877 -40.3 % 24,670 41,302 -40.3 % 1,896 21.0 % 477,683 20.5 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 25.2 % 31.5 % -6.3 % 25.2 % 31.5 % -6.3 % 26.5 % -6.5 % 26.5 % -6.5 % Matched Volume 3 22.3 % 27.2 % -4.9 % 22.3 % 27.2 % -4.9 % 23.2 % -5.5 % 23.2 % -5.5 %  

NYSE Euronext

Monthly Volume Summary - Derivatives Products

                    Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited; contracts in thousands) Dec-09 Dec-08 % Chg Dec-09 Dec-08 % Chg YTD 2009

% Chg vs.

YTD 2008

YTD 2009

% Chg vs.

YTD 2008

  Number of Trading Days - European Markets 22 21 22 21 256 256 Number of Trading Days - U.S. Markets 22 22 22 22 252 252   European Derivatives Products 4,014 2,851 40.8 % 88,311 59,872 47.5 % 4,125 0.6 % 1,056,012 0.6 % of which Bclear 1,102 709 55.5 % 24,252 14,888 62.9 % 1,019 36.7 % 260,950 36.7 %   Total Interest Rate Products 1,821 1,199 51.8 % 40,055 25,188 59.0 % 2,022 -6.7 % 517,700 -6.7 %   Short Term Interest Rate Products 1,743 1,135 53.6 % 38,352 23,841 60.9 % 1,922 -6.9 % 492,024 -6.9 % Medium and Long Term Interest Rate Products 5 77 64 20.7 % 1,703 1,347 26.5 % 100 -2.4 % 25,676 -2.4 %   Total Credit Derivatives Products (Bclear) - - - - - -   Total Equity Products 6 2,148 1,614 33.1 % 47,266 33,892 39.5 % 2,055 9.3 % 526,171 9.3 %   Individual Equity Products 1,614 1,034 56.1 % 35,502 21,713 63.5 % 1,445 19.9 % 369,915 19.9 % Equity Index Products 535 580 -7.8 % 11,763 12,179 -3.4 % 610 -9.7 % 156,255 -9.7 %   of which Bclear 1,102 709 55.5 % 24,252 14,888 62.9 % 1,019 36.7 % 260,950 36.7 % Individual Equity Products 970 613 58.4 % 21,351 12,867 65.9 % 887 39.9 % 226,972 39.9 % Equity Index Products 132 96 37.1 % 2,901 2,021 43.6 % 133 18.8 % 33,978 18.8 %   Commodity Products 45 38 19.3 % 990 793 25.0 % 47 -8.3 % 12,141 -8.3 % of which Bclear - - - - - -   U.S. Derivatives Products   Equity Options 7   NYSE Group Options Contracts 3,092 1,609 92.2 % 68,020 35,395 92.2 % 2,641 44.9 % 665,560 44.4 % Total Consolidated Options Contracts 12,435 9,251 34.4 % 273,562 203,530 34.4 % 13,360 2.9 % 3,366,731 2.5 %   NYSE Group Share of Total 24.9 % 17.4 % 24.9 % 17.4 % 19.8 % 5.8 % 19.8 % 5.8 %   NYSE Liffe U.S.   Futures and Futures Options Volume 19.5 - 428.2 - 17.7 - 4,471.4 -   1 Includes all volume executed in NYSE Group crossing sessions. 2 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 3 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 4 Data included in previously identified categories. 5 Data includes currency products.

6

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 7 Includes trading in U.S. equity options contracts, not equity-index options. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. US Equities data has been updated for Amex integration for October 2008 forward.